Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Medical cooler box for the transportation of specimens (blood/sputum) from the point of specimen collection to the laboratory, used for the TB-PRACTECAL clinical trial. Clinical laboratory specimens must be transported at proper temperatures in order to preserve the viability and integrity of the specimen. Photograph by Alexandra Sadokova
Press release
Press release |
24 April 2025
Transparency

Call for transparency: detailed cost analysis of MSF’s TB-PRACTECAL clinical trial in PLOS Global Public Health

2 min
In Yaoundé, Camaroon, MSF teams provided care to infected patients at the Djoungolo hospital, where Epicentre also carried out operational research activities on the effectiveness of screening tests, in partnership with the national emergency operations center. Photo Credit: Vanessa Fodjo/MSF
Press release
Press release |
15 April 2025
Pandemic preparedness

MSF welcomes progress on Pandemic Agreement negotiations: A step toward equity in future pandemics and health emergencies

4 min
Adré, eastern Chad. A little boy, accompanied by his mother, is getting vaccinated by an MSF staff at the clinic run by the team in Adré transit camp. Our team vaccinated children and teenagers, from 6 months to 14 years, both from the refugee camp and from the surrounding host communities. In Chad, measles outbreaks remain recurrent. Photo credit: Thibault Fendler/MSF
Press release
Press release |
27 March 2025
Vaccines
United States of America

US decision to end support for Gavi puts millions of children’s lives at risk

3 min
Treatment decision algorithms, a hope for the diagnosis of tuberculosis in children. Photo Credit: Stuart Tibaweswa /Epicentre
Press release
Press release |
19 March 2025
Tuberculosis

MSF calls for sustained investments to fight against tuberculosis in children

4 min
Maria Atonio, 43-years-old farmer from Macomia, shows Anti-retro-viral medication after visiting MSF’s Clinic in Nanga, Mozambique. Photo Credit: Martim Gray Pereira/MSF
Press release
Press release |
14 February 2025
HIV/AIDS
United States of America

Uncertainty around PEPFAR program puts millions of people at risk

6 min
Christophe Perrin, TB Advocacy Pharmacist for MSF's Access Campaign presents on Access to Medicines and Diagnostics at the Union World Conference on Lung Health Photo credit: MSF

Christophe Perrin, TB Advocacy Pharmacist for MSF's Access Campaign presents on Access to Medicines and Diagnostics at the Union World Conference on Lung Health

Press release
Press release |
13 November 2024
Tuberculosis

MSF calls for equitable access to TB drugs and diagnostics in first-ever plenary session on access at the TB Union Conference

3 min
MSF and TB activists take stage at TB Union conference 2024 to call on Cepheid and Danaher to reduce the price of GeneXpert tests to US$5 Photo credit: MSF

MSF and TB activists take stage at TB Union conference 2024 to call on Cepheid and Danaher to reduce the price of GeneXpert tests to US$5

Press release
Press release |
12 November 2024
Tuberculosis

MSF and global TB activists take stage at annual TB conference

2 min
Insulin pen for people with diabetes Photo credit: Jinane Saad
Press release
Press release |
11 November 2024
Diabetes

Ahead of World Diabetes Day, pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi must make insulin pens available at $1 per pen

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury